As of 2025-03-26, the Relative Valuation of GeneTether Therapeutics Inc (GTTX.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.10 CAD, the upside of GeneTether Therapeutics Inc based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-03-03 | -7.57 |
| 2025-02-24 | -7.57 |
| 2025-02-20 | -7.57 |
| 2025-02-11 | -9.08 |
| 2025-02-06 | -11.36 |
| 2025-02-03 | -11.36 |
| 2025-01-31 | -9.84 |
| 2025-01-30 | -9.84 |
| 2025-01-29 | -9.84 |
| 2025-01-27 | -9.84 |
| 2025-01-24 | -9.08 |
| 2025-01-22 | -9.08 |
| 2025-01-21 | -11.36 |
| 2025-01-17 | -7.57 |
| 2025-01-15 | -7.57 |
| 2025-01-07 | -9.08 |
| 2024-12-27 | -6.81 |